東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Effects of silymarin on molecular me...

Liu, Rui.

Linked to FindBook

Google Book

Amazon

博客來

Effects of silymarin on molecular mechanisms of non-alcoholic fatty liver disease.

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Effects of silymarin on molecular mechanisms of non-alcoholic fatty liver disease./
Author:	Liu, Rui.
Description:	148 p.
Notes:	Advisers: Linda H. Chen; Craig J. McClain.
Contained By:	Dissertation Abstracts International67-01B.
Subject:	Biology, Animal Physiology. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3201072
ISBN:	9780542483257

Effects of silymarin on molecular mechanisms of non-alcoholic fatty liver disease.
Liu, Rui.

Effects of silymarin on molecular mechanisms of non-alcoholic fatty liver disease. - 148 p.

Advisers: Linda H. Chen; Craig J. McClain.

Thesis (Ph.D.)--University of Kentucky, 2005.

Silymarin, the seed extract of milk thistle (Silybum marianum ), is a mixture of polyphenolic flavonolignans and is a hepatoprotective agent. We hypothesized that Silymarin might modulate mediators, such as the nuclear transcription factors, Sterol Regulatory Element Binding Protein-1 (SREBP-1), Carbohydrate Response Element Binding Protein (ChREBP) and Nuclear factor-kappaB (NF-kappaB), and the hormone, adiponectin, that are involved in the molecular mechanisms of Non-Alcoholic Fatty Liver Disease (NAFLD). C57BL/6, male mice were fed with a standard chow diet or a high carbohydrate diet (HCD) for 5 months and treated with the different doses of silymarin from diet or by gavage. Silymarin improves the antioxidant status in the liver and positively affect plasma lipid profile in mice fed HCD, especially silymarin resulted in the reduction of TBARS, elevated GSH and SAMe contents in the liver. HCD increased the LPS-induced release of tumor necrosis factor-alpha (TNF-alpha) and decreased the secretion of adiponectin. Silymarin decreased the release of LPS-induced TNF-alpha and increased the secretion of adiponectin. HCD increased the levels of P65 in the nuclear extract and p-IkappaB-alpha in the cytosolic extract, the levels of SREBP-1, the levels of ChREBP, and the expression of FAS; high dose of silymarin by gavage decreased their levels. In summary, we successfully developed a fatty liver mouse model by feeding a HCD for a 5-month period. This study indicated that silymarin suppressed oxidative stress induced by HCD and positively influenced hepatic steatosis and liver injury, at least in part, by blocking the increase in SREBP-1, ChREBP, P65 and p-IkappaB-alpha levels, the expression of fatty acid synthase (FAS) and stimulating the secretion of adiponectin in mice. Our data provide a rationale for further exploration of the potential use of silymarin as an alternative and supportive therapy in the treatment of liver disorders such as NAFLD/NASH.

ISBN: 9780542483257Subjects--Topical Terms:

1017835
Biology, Animal Physiology.

Effects of silymarin on molecular mechanisms of non-alcoholic fatty liver disease.
LDR:02926nam 2200289 a 45 001 965661
005 20110906
008 110906s2005 eng d
020 $a 9780542483257
035 $a (UMI)AAI3201072
035 $a AAI3201072
040 $a UMI $c UMI
100 1 $a Liu, Rui. $3 1024143
245 1 0 $a Effects of silymarin on molecular mechanisms of non-alcoholic fatty liver disease.
300 $a 148 p.
500 $a Advisers: Linda H. Chen; Craig J. McClain.
500 $a Source: Dissertation Abstracts International, Volume: 67-01, Section: B, page: 0027.
502 $a Thesis (Ph.D.)--University of Kentucky, 2005.
520 $a Silymarin, the seed extract of milk thistle (Silybum marianum ), is a mixture of polyphenolic flavonolignans and is a hepatoprotective agent. We hypothesized that Silymarin might modulate mediators, such as the nuclear transcription factors, Sterol Regulatory Element Binding Protein-1 (SREBP-1), Carbohydrate Response Element Binding Protein (ChREBP) and Nuclear factor-kappaB (NF-kappaB), and the hormone, adiponectin, that are involved in the molecular mechanisms of Non-Alcoholic Fatty Liver Disease (NAFLD). C57BL/6, male mice were fed with a standard chow diet or a high carbohydrate diet (HCD) for 5 months and treated with the different doses of silymarin from diet or by gavage. Silymarin improves the antioxidant status in the liver and positively affect plasma lipid profile in mice fed HCD, especially silymarin resulted in the reduction of TBARS, elevated GSH and SAMe contents in the liver. HCD increased the LPS-induced release of tumor necrosis factor-alpha (TNF-alpha) and decreased the secretion of adiponectin. Silymarin decreased the release of LPS-induced TNF-alpha and increased the secretion of adiponectin. HCD increased the levels of P65 in the nuclear extract and p-IkappaB-alpha in the cytosolic extract, the levels of SREBP-1, the levels of ChREBP, and the expression of FAS; high dose of silymarin by gavage decreased their levels. In summary, we successfully developed a fatty liver mouse model by feeding a HCD for a 5-month period. This study indicated that silymarin suppressed oxidative stress induced by HCD and positively influenced hepatic steatosis and liver injury, at least in part, by blocking the increase in SREBP-1, ChREBP, P65 and p-IkappaB-alpha levels, the expression of fatty acid synthase (FAS) and stimulating the secretion of adiponectin in mice. Our data provide a rationale for further exploration of the potential use of silymarin as an alternative and supportive therapy in the treatment of liver disorders such as NAFLD/NASH.
590 $a School code: 0102.
650 4 $a Biology, Animal Physiology. $3 1017835
650 4 $a Health Sciences, Medicine and Surgery. $3 1017756
690 $a 0433
690 $a 0564
710 2 0 $a University of Kentucky. $3 1017485
773 0 $t Dissertation Abstracts International $g 67-01B.
790 $a 0102
790 1 0 $a Chen, Linda H., $e advisor
790 1 0 $a McClain, Craig J., $e advisor
791 $a Ph.D.
792 $a 2005
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3201072